A New Twist in Cellular Resistance to the Anticancer Drug Bleomycin-A5

E-ISSN： 1875-5453|11|7|595-602

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.11, Iss.7, 2010-09, pp. : 595-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide: a new anticancer drug?

By Fanelli Massimo Sarmiento Roberta Gattuso Domenico Carillio Guido Capaccetti Barbara Vacca Angelo Roccaro Aldo Maria Gasparini Giampietro

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1211-1225

Informa Healthcare

Access to resources Recommend Favorite

Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2061-2074

Bentham Science Publishers

Access to resources Recommend Favorite

Bleomycin: Revival of an Old Drug

By Mir L.M. Tounekti O. Orlowski S.

General Pharmacology, Vol. 27, Iss. 5, 1996-07 ,pp. : 745-748

Elsevier

Access to resources Recommend Favorite

New methods to assist anticancer drug delivery emerging

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Drug Resistance in Melanoma: New Perspectives

Current Medicinal Chemistry, Vol. 14, Iss. 4, 2007-02 ,pp. : 387-391

Bentham Science Publishers

Access to resources Recommend Favorite